HemosIL Liquid Anti-Xa
Anti-Factor Xa Activity Test System, Apixaban. De Novo DEN190032, from Instrumentation Laboratory CO (Bedford, MA). Product code QLU, class 2.
As of Nov 17, 2026, DEN190032 is an FDA De Novo held by Instrumentation Laboratory CO, granted on Sep 17, 2020 after 450 days, with no recalls tied to it in FDA's recall database.
- Granted: Sep 17, 2020
- Review time: 450 days
- Recalls: 0
- Cited as a predicate by: 3 devices
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFHemosIL Liquid Anti-Xa is an automated chromogenic assay for in vitro diagnostic use by laboratory professionals in clinical laboratories. The assay provides quantitative results on 3.2% citrated human plasma for the following analytes based on the calibrators used: • When used with HemosIL Heparin Calibrators: Quantitative determination of unfractionated heparin (UFH) and low molecular weight…
Pivotal Study
The main clinical evidence FDA relied on, as its decision summary describes it- Design
- Method comparison study of clinical samples from apixaban patients vs. LC-MS/MS reference method
- Enrolled
- 367
- Where
- 3 sites, US
- Primary endpoint
- Agreement with validated apixaban LC-MS/MS method (linear regression of slope, intercept, correlation)
- Result
- n=367; r=0.995; slope 1.101; intercept -2.458; acceptance criteria not stated
Cited as a Predicate
3 later 510(k) summaries name this device as a predicate- INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban…K240315 · Siemens Healthcare Diagnostics Products GmbH · Oct 10, 2024
- HemosIL Liquid Anti-XaK223187 · Instrumentation Laboratory CO · Jun 23, 2023
- HemosIL Liquid Anti-XaK213464 · Instrumentation Laboratory CO · Oct 4, 2022
Other QLU Clearances
The newest 510(k)s for the same product code; see every QLU device- INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban…K240315 · Siemens Healthcare Diagnostics Products GmbH · Oct 10, 2024
- HemosIL Liquid Anti-XaK223187 · Instrumentation Laboratory CO · Jun 23, 2023
Record
- Document
- De Novo decision summary (PDF) ↗
- Type
- Direct
- Received
- Jun 25, 2019
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7295
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files